EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Prognostic Value of Immune-Inflammation Indexes for Breast Cancer Patients Undergoing Endocrine Therapy: A Systematic Review and Meta-analysis

Yue Yang, Bing Shao, Chao Wei, Xuewen Zhang

Clinical Breast Cancer · 2025

DOI: 10.1016/j.clbc.2025.05.010 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Clinical Breast Cancer, 2025. Verfasst von Yue Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical College (Affiliated Hospital), Jining Medical University, Jining Shandong, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Hormonal, Breast Neoplasms, Inflammation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Shandong Provincial Key Laboratory of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Research suggests that systemic immune-inflammation index (SII), neutrophil lymphocyte (NLR), platelet lymphocyte (PLR) and lymphocyte monocyte (LMR) can act as potential prognostic indicators for breast cancer (BC). However, its prognostic value for BC patients undergoing endocrine therapy (ET) remains inconclusive. METHODS: We systematically searched Embase, Cochrane Library, PubMed, and Web of Science for studies on the prognostic significance of immune-inflammation indexes for BC patients undergoing ET from inception to May 5, 2024. Overall survival (OS), progression-free survival (PFS), and disease-free survival (DFS) were the primary outcomes, and they were statistically analyzed by hazard ratios (HR) with 95% confidence intervals (CI). Sensitivity and subgroup analyses were performed to explore the source of heterogeneity. STATA 15.1 and Review Manager 5.4 were adopted for data analyses. RESULTS: Fifteen studies with 27 cohorts of 3168 BC patients undergoing ET were included. The results showed that low NLR was associated with prolonged OS (HR = 2.19, 95% CI, 1.67-2.87; P < .00001) and PFS (HR = 1.64, 95% CI, 1.32-2.04; P < .00001) in overall BC patients receiving ET. High LMR was associated with longer OS (HR = 2.67, 95% CI, 1.64-4.33; P < .0001) in the overall BC patients undergoing ET. Low PLR was significantly associated with prolonged PFS (HR = 1.89, 95% CI, 1.40-2.55; P < .0001). Additionally, low PLR was associated with longer OS (HR = 2.16, 95% CI, 1.03-4.52, P = .04), but sensitivity analysis showed that its significance was not robust enough. All subgroup analyses revealed overall roboust results. CONCLUSION: Immune-inflammation indexes can potentially act as prognostic biomarkers for BC patients undergoing ET, contributing to wiser decision-making in BC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Agents, HormonalBreast NeoplasmsInflammationFemaleHumansBiomarkers, TumorBlood PlateletsLymphocytesMonocytesNeutrophilsPrognosis

Stichwörter der Autor:innen

BCETLMRNLRPLRSIISurvival Outcomes

Substanzen

Antineoplastic Agents, HormonalBiomarkers, Tumor

Autor:innen und Institutionen

  • Medical College (Affiliated Hospital), Jining Medical University, Jining Shandong, China.
  • College of Integrated Traditional Chinese and Western Medicine, Jining Medical University, Jining Shandong, China. Electronic address: qw26010539@163.com.

Förderung

  • the Shandong Provincial Key Laboratory of Traditional Chinese Medicine

Zitieren

APA

Yang, Y., Shao, B., Wei, C., & Zhang, X. (2025). Prognostic Value of Immune-Inflammation Indexes for Breast Cancer Patients Undergoing Endocrine Therapy: A Systematic Review and Meta-analysis. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.05.010

Vancouver

Yang Y, Shao B, Wei C, Zhang X. Prognostic Value of Immune-Inflammation Indexes for Breast Cancer Patients Undergoing Endocrine Therapy: A Systematic Review and Meta-analysis. Clinical Breast Cancer. 2025. doi:10.1016/j.clbc.2025.05.010

BibTeX
@article{Yang2025,
  author = {Yang, Yue and Shao, Bing and Wei, Chao and Zhang, Xuewen},
  title = {Prognostic Value of Immune-Inflammation Indexes for Breast Cancer Patients Undergoing Endocrine Therapy: A Systematic Review and Meta-analysis},
  journal = {Clinical Breast Cancer},
  year = {2025},
  doi = {10.1016/j.clbc.2025.05.010}
}
Kostenlos starten →